eprazinone (CHEBI:82716)

ChEBI > Main

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name	eprazinone

ChEBI ID	CHEBI:82716

Definition	A member of the class of piperazines in which the two amino hydrogens of piperazine are replaced by 2-benzoylpropyl and 2-ethoxy-2-phenylethyl groups.

Stars	This entity has been manually annotated by the ChEBI Team.

Submitter	Toni Morrison

Supplier Information

Download	Molfile XML SDF

Wikipedia	License

Read full article at Wikipedia

Formula

C24H32N2O2

Net Charge

Average Mass

380.52310

Monoisotopic Mass

380.24638

InChI

InChI=1S/C24H32N2O2/c1-3-28-23(21-10-6-4-7-11-21)19-26-16-14-25(15-17-26)18-20(2)24(27)22-12-8-5-9-13-22/h4-13,20,23H,3,14-19H2,1-2H3

InChIKey

BSHWLCACYCVCJE-UHFFFAOYSA-N

SMILES

CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1

Roles Classification
Chemical Role(s):	Bronsted base A molecular entity capable of accepting a hydron from a donor (Bronsted acid). (via organic amino compound )

Application(s):	mucolytic A compound that alters the structure of mucus so as to decrease its viscosity and thereby facilitate its removal by ciliary action and expectoration. Compare with antitussives, which suppress the cough reflex, and expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing.

ChEBI Ontology
Outgoing	eprazinone (CHEBI:82716) has role mucolytic (CHEBI:77034) eprazinone (CHEBI:82716) is a N-alkylpiperazine (CHEBI:46845) eprazinone (CHEBI:82716) is a aromatic ketone (CHEBI:76224) eprazinone (CHEBI:82716) is a ether (CHEBI:25698) eprazinone (CHEBI:82716) is conjugate base of eprazinone(2+) (CHEBI:83323)

Incoming	eprazinone(2+) (CHEBI:83323) is conjugate acid of eprazinone (CHEBI:82716)

IUPAC Name

3-[4-(2-ethoxy-2-phenylethyl)piperazin-1-yl]-2-methyl-1-phenylpropan-1-one

Synonyms	Sources
1-(2-Phenyl-2-ethoxyethyl)-4-(2-benzyloxypropyl)piperazine	ChemIDplus
3-(4-(beta-Ethoxyphenethyl)-1-piperazinyl)-2-methylpropiophenone	ChemIDplus

Last Modified

22 February 2017